Digital media and technology provider Catenai (LON: CTAI) says AI firm Klarian intends to repay the £450,000 loan provided one year ago. Including fees the total amount repayable is £567,500. These funds will be used by Catenai to invest in AI opportunities. The share price jumped 29.4% to 0.22p.
Atome (LON: ATOM) has signed a definitive Engineering, Procurement and Construction (EPC) contract with Casale for its Villeta green fertiliser project in Paraguay. This is a fixed price contract of $465m and will enable progress to the final investment decision for the 145MW project. That could happen in June and production could start 38 months later. The share price moved ahead by 14.3% to 32p.
Power and data transmission products manufacturer Volex (LON: VLX) benefited from a strong fourth quarter with full year revenues expected to be $1.06bn, up 16%. Operating profit should be at least $100m, which is better than expected. Increased demand for data centre products improved margins. Most divisions improved sales, but the medical sector revenues declined because of catch-up orders in the previous year. Off-highway revenues were flat. The share price rose 10.2% to 219p, recovering some of the loss because of tariff concerns, although additional costs are expected to be passed on to clients.
Energy-as-a-Service provider eEnergy Group (LON: EAAS) continues to win contracts. The latest is with University Hospitals Plymouth NHS Trust and is worth £518,000. This is for providing LED lighting for 19 wards at Plymouth Derriford hospital. The share price increased 4.55% to 4.6p.
FALLERS
Organ transplant diagnostics developer Verici Dx (LON: VRCI) is still waiting for the local coverage determination for Tutivia reimbursement, so revenues on the tests cannot be recognised yet. There were 292 tests ordered in the first quarter of 2025. Tariffs and economic uncertainty have delayed potential licencing deals. Expected royalties from the Thermo Fisher deal have also been delayed. Cash is $1.63m but it will run out by June. Around $5m will be required in a share issue to extend the cash position by 12 months. This should happen when the local coverage determination is received. Singer has cut 2025 estimated revenues from $11.6m to $4.4m. The share price halved to 1.625p.
Peru-focused gold explorer Nativo Resources (LON: NTVO) is undertaking a feasibility study at he Toma La Mano tailings dump and there are other tailings dumps that are being considered. This will require additional funding. Peterhouse is subscribing for 12 million shares at 0.15p each, which gives the broker a 19.4% stake. This will be used to offset fees and Peterhouse will try to place the shares and provide Nativo Resources with 95% of the proceeds. Cash is being carefully managed, and some directors will receive their salary in shares. Further funds will be required by May and there are discussions with finance providers. Debt is being restructured. The share price slipped 38.8%
Although semiconductor designer EnSilica (LON: ENSI) has won six design and supply contracts in the first ten months of the financial year, two have been delayed which will hit revenues this year. Full year revenues are expected to be between £19m and £20m, compared with the £29m previously anticipated. EnSilica will make a loss. Expectations for next year have been slightly reduced to up to £35m, with four-fifths covered by existing contracts. The share price declined 22.4% to 30.25p, which is a new low.
Wellnex Life (LON: WNX) shares are continuing their decline since joining AIM on 28 March. The shares were already trading on the ASX before the placing and offer at 31.75p. The consumer healthcare company is trying to expand outside of Australia. The share price dipped 20.8% to 19p.